Paolo Marzano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Paolo Marzano has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Domenico Mavilio
Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
15 shared publications - Joanna Mikulak
Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
15 shared publications - Valentina Cazzetta
Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy
14 shared publications - Anna Carletti
Unit of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Italy
12 shared publications - Guido Costa
Department of Biomedical Sciences, Humanitas University, Milan, Italy
12 shared publications - Guido Torzilli
Department of Biomedical Sciences, Humanitas University, Milan, Italy
12 shared publications
Latest Publications
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 3. List of significant genes (FDR-adjusted p-value < 0.05, and |Log2-FoldChange| > 0.25, detected in not less than 10% of cells) identified from the comparison Liver vs Colon within the inflammatory or immunoregulatory TAMs. In green are indicated the genes up-regulated in the liver, while in orange are indicated the colon-associated ones. Table related to Fig. 5A.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 3. List of significant genes (FDR-adjusted p-value < 0.05, and |Log2-FoldChange| > 0.25, detected in not less than 10% of cells) identified from the comparison Liver vs Colon within the inflammatory or immunoregulatory TAMs. In green are indicated the genes up-regulated in the liver, while in orange are indicated the colon-associated ones. Table related to Fig. 5A.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 5. Differences between inflammatory and immunoregulatory TAMs in colon and liver
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 5. Differences between inflammatory and immunoregulatory TAMs in colon and liver
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 2. Transcriptomic characterization of healthy liver and Kupffer cells
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 2. Transcriptomic characterization of healthy liver and Kupffer cells
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 4. Pseudotime trajectory analysis shows macrophage blood derivation
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 4. Pseudotime trajectory analysis shows macrophage blood derivation
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table S2: List of genes used to compute the gene module scores related to the antigen-presentation (n genes = 24), lipid-associated (n genes = 32), angiogenic (n genes = 31), and cytotoxic-inflammatory (n genes = 21) macrophage scores. Table related to Fig. 2E, 3E-G, supplementary figure 2F, and supplementary figure 3E.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table S2: List of genes used to compute the gene module scores related to the antigen-presentation (n genes = 24), lipid-associated (n genes = 32), angiogenic (n genes = 31), and cytotoxic-inflammatory (n genes = 21) macrophage scores. Table related to Fig. 2E, 3E-G, supplementary figure 2F, and supplementary figure 3E.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 1. scRNA-sequencing analysis of early phases synchronous CRLM patients
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 1. scRNA-sequencing analysis of early phases synchronous CRLM patients
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 4. List of genes used to compute the gene module scores related to the cell cycle proliferation score (n genes = 57). Table related to Fig. 5D.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 4. List of genes used to compute the gene module scores related to the cell cycle proliferation score (n genes = 57). Table related to Fig. 5D.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Table S1 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 1. List of significant genes (FDR-adjusted p-value < 0.05, and |Log2-FoldChange| > 0.25, detected in not less than 10% of cells) identified from in each tissue-specific cluster within pathologic colon, liver, and peripheral blood. Table related to Fig. 2D, 3D, and supplementary figure 3B.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Table 1. List of significant genes (FDR-adjusted p-value < 0.05, and |Log2-FoldChange| > 0.25, detected in not less than 10% of cells) identified from in each tissue-specific cluster within pathologic colon, liver, and peripheral blood. Table related to Fig. 2D, 3D, and supplementary figure 3B.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 3. Transcriptomic characterization of pathologic and healthy monocytes in the peripheral blood
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Supplementary Figure 3. Transcriptomic characterization of pathologic and healthy monocytes in the peripheral blood
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Early synchronous colorectal liver metastasis (CRLM) represents a clinical condition characterized by the simultaneous presence of primary colorectal cancer and metastatic liver lesions. In this study, we characterized the tissue-specific transcriptomes, phenotypes, and functional relevance of tumor-associated macrophages (TAM) within the tumor microenvironment (TME) of colorectal cancer and CRLM specimens from patients who underwent simultaneous surgical removal of these malignancies. The high-throughput single-cell transcriptional analysis revealed an inverse ratio of inflammatory and immunoregulatory TAMs in the colorectal cancer and CRLM TMEs, along with heterogeneity in both tumoral tissues. Furthermore, we found that inflammatory TAMs in colorectal cancer expressed inhibitory ligands that might support immune escape, thus favoring liver metastatic progression. In contrast, CRLM lesions possessed a highly immunosuppressive milieu characterized by large proliferative CTLA4+ immunoregulatory TAMs and the presence of IL7R+ cytotoxic TAMs. Higher frequencies of these specific TAM subsets in CRLM were associated with shorter disease-free survival and worse patient prognosis. The identification and characterization of immunoregulatory TAMs preferentially enriched in CRLM is key for the development of novel immunotherapeutic strategies aimed at boosting anticancer immune responses within the TME.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Tissue-Specific Immunosuppressive and Proliferating Macrophages Fuel Early Metastatic Progression of Human Colorectal Cancer to the Liver
Early synchronous colorectal liver metastasis (CRLM) represents a clinical condition characterized by the simultaneous presence of primary colorectal cancer and metastatic liver lesions. In this study, we characterized the tissue-specific transcriptomes, phenotypes, and functional relevance of tumor-associated macrophages (TAM) within the tumor microenvironment (TME) of colorectal cancer and CRLM specimens from patients who underwent simultaneous surgical removal of these malignancies. The high-throughput single-cell transcriptional analysis revealed an inverse ratio of inflammatory and immunoregulatory TAMs in the colorectal cancer and CRLM TMEs, along with heterogeneity in both tumoral tissues. Furthermore, we found that inflammatory TAMs in colorectal cancer expressed inhibitory ligands that might support immune escape, thus favoring liver metastatic progression. In contrast, CRLM lesions possessed a highly immunosuppressive milieu characterized by large proliferative CTLA4+ immunoregulatory TAMs and the presence of IL7R+ cytotoxic TAMs. Higher frequencies of these specific TAM subsets in CRLM were associated with shorter disease-free survival and worse patient prognosis. The identification and characterization of immunoregulatory TAMs preferentially enriched in CRLM is key for the development of novel immunotherapeutic strategies aimed at boosting anticancer immune responses within the TME.